Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toyota Tsusho America, Inc. (TAI) is a multi-market trading and investment company and a subsidiary of Toyota Tsusho Corporation, the trading arm of the Toyota Group. The company operates a dedicated Medical & Healthcare business unit that focuses on the distribution of medical devices, pharmaceutical ingredients, and advanced healthcare technologies. TAI leverages its extensive global supply chain and logistics expertise to facilitate market entry and expansion for life science companies in North America. Beyond distribution, the company is increasingly involved in strategic investments and partnerships within the digital health, wellness, and regenerative medicine sectors. TAI serves as a bridge between innovative manufacturers and healthcare providers, offering value-added services such as financing, business development, and regulatory support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toyota Tsusho America.